Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
Health and Me on MSN1d
Yearly Jab For HIV Protection Is Now Almost HereA yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...
Montgomery Advertiser on MSN2d
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.
4d
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.
Priscilla Tsondai, MD, MPH, breaks down top care gaps as opportunities for care improvement.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback